1 Brunn H. Two interesting benign lung tumors of contradictory histopathology. Remarks on the necessity for maintaining the chest tumor registry. J Thorac Cardiovasc Surg. 1939;9(2):119–31.
2 Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F (Eds.). WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: WHO Press; 2013. pp. 83–4.
3 Andrade NN, Mathai P C, Kamil R, Aggarwal N. Inflammatory myofibroblastic tumour: A case report and a clinical update. J Oral Biol Craniofac Res. 2017;7(3):219–22.
4 Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14(6):569–76.
5 Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, et al. Inflammatory myofibroblastic tumors. J Surg Oncol. 2006;94(5):385–91.
6 Takeda S, Onishi Y, Kawamura T, Maeda H. Clinical spectrum of pulmonary inflammatory myofibroblastic tumor. Interact Cardiovasc Thorac Surg. 2008;7(4):629–33.